Vimarsana
Biggest News Aggregation in the World

Page 28 - Bioscience Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioscience Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioscience Inc Today - Breaking & Trending Today

Yield10 Bioscience, Inc. (NASDAQ:YTEN) Major Shareholder Jack W. Schuler Buys 765,000 Shares - Vimarsana News

Yield10 Bioscience, Inc. (NASDAQ:YTEN) Major Shareholder Jack W. Schuler Buys 765,000 Shares

Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Free Report) major shareholder Jack W. Schuler acquired 765,000 shares of the firm’s stock in a transaction on Tuesday, August 15th. The stock was bought at an average price of $0.65 per share, with a total value of $497,250.00. Following the completion of the acquisition, the insider now directly […]

Critical Survey: YaSheng Group (OTCMKTS:HERB) versus TerrAscend (OTCMKTS:TSNDF) - Vimarsana News

Critical Survey: YaSheng Group (OTCMKTS:HERB) versus TerrAscend (OTCMKTS:TSNDF)

YaSheng Group (OTCMKTS:HERB – Get Free Report) and TerrAscend (OTCMKTS:TSNDF – Get Free Report) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, profitability and risk. Earnings and Valuation This table compares YaSheng […]

Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Grupo Aeroportuario (NYSE:ASR), Accolade (NASDAQ:ACCD) - Vimarsana News

Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Grupo Aeroportuario (NYSE:ASR), Accolade (NASDAQ:ACCD)

Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent value right of $1.00 per ADS.

Assembly Biosciences Promising Candidate for Chronic Hepatitis D Virus HDV Treatment - Vimarsana News

Assembly Biosciences Promising Candidate for Chronic Hepatitis D Virus HDV Treatment

Leading biotech company Assembly Biosciences has recently announced the selection of ABI-6250 as a promising candidate for the treatment of chronic hepatitis

INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERS - Vimarsana News

INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERS

SARASOTA, Fla., Sept. 29, 2023 /PRNewswire/ -- INVO Bioscience, Inc. today announced that its special meeting of shareholders on September 29, 2023 was convened and then adjourned, without...